The news of Pfizer’s departure from their New London campus startled us all this week, but as more facts unfolded we were able to focus on the positives.

Pfizer will, in fact, remain in Connecticut, transferring their workers across the river to their Groton facility. Their workers will continue to advance our local economy. In addition, Pfizer’s ongoing support of the region through its philanthropic and volunteer efforts will add immeasurably to the quality of life in eastern Connecticut. From that standpoint, the news is not all bad. In fact, compared to other Pfizer communities throughout the country we in eastern Connecticut are very fortunate. The Groton facility will be the largest research and development center in the Pfizer portfolio.

Although the decision is hard on New London and its tax base, the fact remains that Pfizer and its multi-million dollar building and the dramatically improved grounds it sits on will continue in the future as a major asset for New London and the region.

At the Chamber, we will continue to do our part to ensure that Pfizer remains an important economic entity in eastern Connecticut and we extend our support and best wishes to the Pfizer community for continued successes.

admin